Scholarlink

<p>Acute kidney injury (AKI) in children remains a significant challenge, independently associated with increased morbidity and mortality. Historically, kidney support therapy (KST) for this vulnerable population was fraught with difficulties due to small patient size, required extracorporeal volumes, and the risk of hemodynamic instability. However, the last few decades have seen dramatic advances in technology and therapeutic strategies, transforming the landscape of pediatric KST. The introduction of neonatal-specific continuous KST machines, such as the CARPEDIEM, NIDUS, and the Aquadex system, marks a revolutionary step. These devices are designed with minimal extracorporeal volumes, enabling precise fluid balance control and highly efficient solute clearance. Hybrid therapies are increasingly being used to leverage advantages of intermittent and continuous modalities. Peritoneal dialysis (PD) remains an accessible and safe first-line treatment, particularly for hemodynamically unstable neonates or in resource-limited settings. Use of closed system, automated cyclers, and continuous flow PD have enhanced safety of PD in AKI. Advances in precision KST using artificial intelligence, regenerative therapies, and multidisciplinary collaborations constitute an emerging space to watch in coming years. Future research needs to prioritize trials to further refine and standardize KST for children with AKI, ultimately improving lifelong outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Kidney Support Therapy: Recent Advances

  • 期刊论文

  • 发表日期：

    2026年3月26日

查看全文
  • Menka Yadav

摘要

Acute kidney injury (AKI) in children remains a significant challenge, independently associated with increased morbidity and mortality. Historically, kidney support therapy (KST) for this vulnerable population was fraught with difficulties due to small patient size, required extracorporeal volumes, and the risk of hemodynamic instability. However, the last few decades have seen dramatic advances in technology and therapeutic strategies, transforming the landscape of pediatric KST. The introduction of neonatal-specific continuous KST machines, such as the CARPEDIEM, NIDUS, and the Aquadex system, marks a revolutionary step. These devices are designed with minimal extracorporeal volumes, enabling precise fluid balance control and highly efficient solute clearance. Hybrid therapies are increasingly being used to leverage advantages of intermittent and continuous modalities. Peritoneal dialysis (PD) remains an accessible and safe first-line treatment, particularly for hemodynamically unstable neonates or in resource-limited settings. Use of closed system, automated cyclers, and continuous flow PD have enhanced safety of PD in AKI. Advances in precision KST using artificial intelligence, regenerative therapies, and multidisciplinary collaborations constitute an emerging space to watch in coming years. Future research needs to prioritize trials to further refine and standardize KST for children with AKI, ultimately improving lifelong outcomes.